Revolution Medicines D
D
RVMD
172.280
USD
-4.01
(-2.27%)
Post Trading·172.020USD-0.260(-0.15%)
Last updated: · Delayed 15 min
Revolution Medicines cash flow statement 2017–2026What is a cash flow statement? The cash flow statement shows the cash that came into a company and went out over a period, split into operating, investing and financing activities.
Revolution Medicines's free cash flow over the last twelve months was -1.44B USD: operating cash flow of -1.43B USD less 9.45M USD of capital spending.
Operating cash flow Free cash flow
Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.
| Fiscal year | TTM 30 Sept 2026 | FY2025 31 Dec 2025 | FY2024 31 Dec 2024 | FY2023 31 Dec 2023 | FY2022 31 Dec 2022 | FY2021 31 Dec 2021 | FY2020 31 Dec 2020 | FY2019 31 Dec 2019 | FY2018 31 Dec 2018 | FY2017 31 Dec 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Net income | -1.87B | -1.13B | -600.09M | -436.37M | -248.71M | -187.09M | -108.16M | -47.66M | -41.79M | -31.13M |
Depreciation and amortization | 16.70M | 16.56M | 11.82M | 9.31M | 9.66M | 7.33M | 6.55M | 3.34M | 1.76M | 1.19M |
Stock-based compensation | — | 118.39M | 79.20M | 61.77M | 31.20M | 20.72M | 8.89M | 3.16M | 855.00K | 141.00K |
Change in working capital | -112.57M | 86.82M | 1.17M | 40.66M | -13.49M | 8.72M | -8.30M | -4.46M | 38.06M | 4.65M |
Change in receivables | — | 0.00 | 1.25M | 3.42M | 1.26M | 464.00K | 2.34M | -1.43M | -7.30M | 0.00 |
Change in inventory | — | 0.00 | 0.00 | 0.00 | 0.00 | 7.68M | -2.34M | 0.00 | 0.00 | 0.00 |
Change in payables | 25.19M | 9.54M | -6.47M | 32.47M | 7.29M | 2.24M | 305.00K | 5.26M | 109.00K | 1.97M |
Change in other working capital | 103.98M | 77.29M | 6.38M | 4.77M | -22.03M | -1.66M | -8.61M | -8.29M | 37.95M | 2.68M |
Other non-cash items | 353.76M | 11.79M | -48.77M | -22.04M | -2.64M | 3.13M | 1.34M | 373.00K | 2.12M | 549.00K |
Operating cash flowWhat is a cash flow statement? The cash flow statement shows the cash that came into a company and went out over a period, split into operating, investing and financing activities. | -1.43B | -897.74M | -557.44M | -350.57M | -224.40M | -147.18M | -100.06M | -49.62M | 1.21M | -25.15M |
Operating cash flow growth | — | — | — | — | — | — | — | -4,190.35% | — | — |
Capital expenditure | -9.45M | -15.99M | -10.31M | -7.73M | -10.82M | -6.53M | -2.93M | -2.59M | -1.50M | -1.58M |
Acquisitions | — | 0.00 | 0.00 | 0.00 | 13.30M | 135.59M | 231.30M | 6.20M | 160.00K | 0.00 |
Purchases of investments | -3.09B | -1.79B | -2.14B | -1.06B | -612.77M | -671.34M | -544.13M | -172.27M | 0.00 | 0.00 |
Sales and maturities of investments | 1.76B | 1.93B | 1.59B | 724.05M | 599.47M | 535.75M | 312.83M | 66.69M | 0.00 | 0.00 |
Other investing | — | 0.00 | 0.00 | 0.00 | -13.30M | -135.59M | -231.30M | 0.00 | 0.00 | 0.00 |
Investing cash flow | -1.33B | 118.06M | -554.39M | -342.60M | -24.12M | -142.12M | -234.23M | -101.97M | -1.34M | -1.58M |
Debt issued (repaid) | — | 244.22M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Shares issued | 2.44B | 377.09M | 959.13M | 392.39M | 298.05M | 291.24M | 420.07M | 98.70M | 420.00K | 74.00K |
Share buybacksWhat are stock buybacks? A stock buyback is a company buying its own shares on the market. With fewer shares left, each remaining share owns a bigger part of the company. | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -45.00K | -131.00K | 0.00 |
Dividends paid | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other financing | — | 220.00K | 284.00K | 836.81M | 3.39M | 2.94M | 2.71M | 0.00 | 289.00K | 22.66M |
Financing cash flow | 3.17B | 621.52M | 959.41M | 1.23B | 301.43M | 294.18M | 422.78M | 98.66M | 60.85M | 22.66M |
Net change in cash | 409.44M | -158.16M | -153.08M | 534.74M | 52.92M | 4.88M | 88.48M | -52.93M | 60.72M | -4.06M |
Free cash flowWhat is free cash flow (FCF)? Free cash flow is the cash a company's operations bring in minus what it spends on long-term assets (capex): cash left for debt, dividends and buybacks. | -1.44B | -913.73M | -567.74M | -358.30M | -235.22M | -153.71M | -103.00M | -52.21M | -286.00K | -26.72M |
Free cash flow margin | — | — | — | -3,094.14% | -664.83% | -522.99% | -239.62% | -104.32% | -1.42% | — |
Free cash flow per share | -7.08 | -4.81 | -3.38 | -3.17 | -2.92 | -2.11 | -1.55 | -1.43 | -0.01 | -0.73 |
Income taxes paid | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter | Q3 FY2026 30 Sept 2026 | Q2 FY2026 30 Jun 2026 | Q1 FY2026 31 Mar 2026 | Q4 FY2025 31 Dec 2025 | Q3 FY2025 30 Sept 2025 | Q2 FY2025 30 Jun 2025 | Q1 FY2025 31 Mar 2025 | Q4 FY2024 31 Dec 2024 | Q3 FY2024 30 Sept 2024 | Q2 FY2024 30 Jun 2024 | Q1 FY2024 31 Mar 2024 | Q4 FY2023 31 Dec 2023 | Q3 FY2023 30 Sept 2023 | Q2 FY2023 30 Jun 2023 | Q1 FY2023 31 Mar 2023 | Q4 FY2022 31 Dec 2022 | Q3 FY2022 30 Sept 2022 | Q2 FY2022 30 Jun 2022 | Q1 FY2022 31 Mar 2022 | Q4 FY2021 31 Dec 2021 | Q3 FY2021 30 Sept 2021 | Q2 FY2021 30 Jun 2021 | Q1 FY2021 31 Mar 2021 | Q4 FY2020 31 Dec 2020 | Q3 FY2020 30 Sept 2020 | Q2 FY2020 30 Jun 2020 | Q1 FY2020 31 Mar 2020 | Q4 FY2019 31 Dec 2019 | Q3 FY2019 30 Sept 2019 | Q2 FY2019 30 Jun 2019 | Q1 FY2019 31 Mar 2019 | Q4 FY2018 31 Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income | -407.46M | -644.37M | -453.82M | -364.89M | -305.21M | -247.79M | -213.42M | -194.57M | -156.29M | -133.23M | -116.00M | -161.54M | -108.43M | -98.30M | -68.10M | -56.51M | -73.33M | -61.22M | -57.65M | -52.68M | -52.94M | -44.30M | -37.18M | -34.20M | -27.22M | -27.22M | -19.52M | -14.60M | -12.82M | -10.12M | -10.13M | -11.34M |
Depreciation and amortization | 2.96M | 4.50M | 4.54M | 4.70M | 4.34M | 3.80M | 3.72M | 3.39M | 2.88M | 2.80M | 2.76M | 2.86M | 2.15M | 1.77M | 2.53M | 2.60M | 2.43M | 2.33M | 2.29M | 2.06M | 1.75M | 1.84M | 1.68M | 1.70M | 1.63M | 1.67M | 1.54M | 865.00K | 873.00K | 811.00K | 793.00K | 691.00K |
Stock-based compensation | 62.63M | 0.00 | 87.30M | 33.70M | 30.78M | 28.83M | 25.08M | 22.44M | 20.78M | 19.78M | 16.21M | 25.43M | 13.67M | 12.98M | 9.70M | 8.32M | 8.14M | 8.10M | 6.64M | 6.20M | 5.83M | 5.31M | 3.39M | 2.63M | 2.67M | 2.02M | 1.57M | 1.40M | 854.00K | 506.00K | 403.00K | 281.00K |
Change in working capital | -142.95M | 15.08M | -16.95M | 32.25M | 56.44M | -4.30M | 2.44M | 42.78M | 13.13M | -4.74M | -47.21M | 21.20M | 1.14M | 21.28M | -2.95M | -13.60M | 12.18M | -4.95M | -7.11M | 4.25M | 7.78M | 2.37M | -5.67M | 4.25M | -4.50M | 3.47M | -11.51M | 648.00K | -2.54M | -2.67M | -4.26M | -1.61M |
Change in receivables | -230.72M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||||
Change in inventory | -11.02M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||||
Change in payables | 13.81M | 5.03M | 16.86M | -10.50M | 19.55M | 8.76M | -8.27M | 29.36M | -2.79M | -4.08M | ||||||||||||||||||||||
Change in other working capital | 84.99M | 10.04M | -33.80M | 42.75M | 36.90M | -13.06M | 10.71M | 13.42M | 15.92M | -660.00K | ||||||||||||||||||||||
Other non-cash items | 71.51M | 237.48M | 24.76M | 20.01M | 6.34M | -2.30M | -12.26M | -11.57M | -10.91M | -12.77M | -16.32M | -8.47M | -5.14M | -4.85M | -3.58M | -2.17M | -1.16M | 27.00K | 667.00K | 907.00K | 997.00K | 693.00K | 534.00K | 586.00K | 400.00K | 87.00K | -105.00K | 33.00K | -224.00K | -29.00K | 593.00K | 201.00K |
Operating cash flowWhat is a cash flow statement? The cash flow statement shows the cash that came into a company and went out over a period, split into operating, investing and financing activities. | -415.65M | -387.32M | -354.17M | -274.24M | -207.31M | -221.76M | -194.44M | -138.29M | -130.42M | -128.17M | -160.56M | -120.56M | -100.50M | -67.12M | -62.39M | -61.79M | -51.74M | -55.72M | -55.16M | -39.27M | -36.59M | -34.08M | -37.25M | -25.03M | -27.02M | -19.99M | -28.02M | -11.65M | -13.86M | -11.50M | -12.61M | -11.78M |
Operating cash flow growth | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||
Capital expenditure | -3.70M | -2.29M | -1.54M | -1.93M | -3.35M | -7.45M | -3.27M | -1.22M | -3.52M | -2.40M | -3.17M | -2.32M | -2.54M | -1.12M | -1.76M | -2.88M | -3.53M | -2.53M | -1.89M | -1.18M | -454.00K | -1.31M | -3.58M | -1.17M | -687.00K | -474.00K | -603.00K | -510.00K | -1.11M | -631.00K | -341.00K | -216.00K |
Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 42.43M | -5.75M | 4.23M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 160.00K |
Purchases of investments | -540.75M | -2.04B | -209.73M | -296.49M | -459.04M | -529.29M | -510.04M | -695.21M | -364.88M | -374.86M | -701.68M | -519.61M | -170.04M | -176.18M | -193.10M | -160.34M | -212.96M | -127.65M | -111.82M | -110.81M | -168.25M | -278.24M | -114.04M | -44.88M | -194.05M | -205.17M | -100.04M | -28.58M | -88.28M | -55.41M | 0.00 | 0.00 |
Sales and maturities of investments | 624.54M | 381.98M | 383.89M | 373.29M | 487.24M | 571.02M | 497.35M | 303.53M | 346.93M | 485.20M | 456.88M | 141.52M | 249.93M | 133.75M | 198.85M | 156.11M | 93.05M | 192.58M | 157.73M | 120.53M | 138.53M | 156.77M | 119.93M | 108.99M | 93.77M | 69.15M | 40.93M | 37.11M | 29.58M | 0.00 | 0.00 | 0.00 |
Other investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -42.43M | 5.75M | -4.23M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.00K | 5.00K | 85.00K | 6.10M | 160.00K |
Investing cash flow | 80.10M | -1.66B | 172.62M | 74.88M | 24.85M | 34.28M | -15.95M | -392.90M | -21.47M | 107.94M | -247.97M | -380.40M | 77.35M | -43.54M | 4.00M | -7.10M | -123.44M | 62.40M | 44.03M | 8.53M | -30.18M | -122.78M | 2.31M | 62.95M | -100.97M | -136.50M | -59.72M | 8.02M | -59.80M | -55.95M | 5.76M | -56.00K |
Debt issued (repaid) | -1.00K | 732.07M | 0.00 | 244.22M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Shares issued | 147.16M | 1.69B | 239.00M | 365.47M | 4.15M | 6.58M | 892.00K | 873.52M | 74.29M | 7.50M | 810.00K | 2.55M | 1.01M | 62.05M | 323.71M | 49.92M | 248.13M | 1.43M | 305.00K | 10.10M | 319.00K | -564.00K | 281.71M | -34.00K | 167.80M | -1.33M | 253.72M | 0.00 | 0.00 | 0.00 | 0.00 | 19.00K |
Share buybacksWhat are stock buybacks? A stock buyback is a company buying its own shares on the market. With fewer shares left, each remaining share owns a bigger part of the company. | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -5.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other financing | -165.00K | 0.00 | -252.00K | -244.02M | -5.74M | 250.00M | -18.00K | 284.00K | 3.00M | 0.00 | 0.00 | 836.81M | 0.00 | 2.58M | 499.00K | 1.44M | 209.00K | 0.00 | 0.00 | 632.00K | 0.00 | 1.43M | 555.00K | 1.52M | 1.08M | 0.00 | 27.00K | -1.53M | 144.00K | 90.17M | 14.00K | -131.00K |
Financing cash flow | 147.00M | 2.42B | 238.74M | 365.66M | -1.59M | 256.58M | 874.00K | 873.81M | 77.29M | 7.50M | 810.00K | 839.35M | 1.01M | 64.63M | 324.21M | 51.36M | 248.34M | 1.43M | 305.00K | 10.73M | 319.00K | 868.00K | 282.26M | 1.49M | 168.88M | -1.34M | 253.74M | -1.53M | 10.01M | 90.17M | 14.00K | 4.22M |
Net change in cash | -188.56M | 374.50M | 57.19M | 166.30M | -184.05M | 69.10M | -209.51M | 341.80M | -74.59M | -12.72M | -407.72M | 337.75M | -21.93M | -46.04M | 265.81M | -17.53M | 73.16M | 8.11M | -10.83M | -20.00M | -66.45M | -156.00M | 247.33M | 39.40M | 40.90M | -158.69M | 166.01M | -5.17M | -63.65M | 22.72M | -6.83M | -7.61M |
Free cash flowWhat is free cash flow (FCF)? Free cash flow is the cash a company's operations bring in minus what it spends on long-term assets (capex): cash left for debt, dividends and buybacks. | -419.35M | -389.61M | -355.70M | -276.16M | -210.66M | -229.21M | -197.70M | -139.51M | -133.94M | -130.57M | -163.73M | -122.88M | -103.03M | -68.24M | -64.15M | -64.66M | -55.26M | -58.24M | -57.05M | -40.45M | -37.04M | -35.39M | -40.83M | -26.20M | -27.71M | -20.47M | -28.62M | -12.16M | -14.96M | -12.13M | -12.95M | -11.99M |
Free cash flow margin | -212.26% | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||
Free cash flow per share | -1.95 | -1.85 | -1.80 | -1.45 | -1.11 | -1.22 | -1.05 | -0.83 | -0.80 | -0.79 | -0.99 | -0.87 | -0.94 | -0.64 | -0.68 | -0.73 | -0.65 | -0.78 | -0.77 | -0.55 | -0.50 | -0.48 | -0.58 | -0.40 | -0.43 | -0.35 | -0.98 | -0.33 | -0.41 | -0.33 | -0.35 | -0.33 |
Income taxes paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
Common questions about Revolution Medicines's cash flow
Source: Financial Modeling PrepVerified against SEC filings